JH Beijnen

474 citations
15 papers · 364 indexed · h-index 11
Topics
Cancer Treatment and Pharmacology (4 papers)Hematopoietic Stem Cell Transplantation (3 papers)Chemotherapy-related skin toxicity (3 papers)

In The Last Decade

JH Beijnen

14 papers receiving 354 citations

Peers

JH Beijnen
Comparison fields: 5 of 75
  • Oncology 132
  • Infectious Diseases 91
  • Molecular Biology 78
  • Virology 63
  • Pathology and Forensic Medicine 43
Replace Angkana Charoenyingwattana with:
Angkana Charoenyingwattana Thailand
Carla L. Bregman United States
Jacqueline L. Olin United States
Martin P. Zanni Switzerland
Danijela Konforte Canada
D Mauri-Hellweg Switzerland
Salomé von Greyerz Switzerland
Avi Hassner Israel
T. Tan Singapore
Thao Doan United States
JH Beijnen relative to Angkana Charoenyingwattana Thailand Angkana Charoenyingwattana's profile →
Citations per field
00.5×6.3×
Angkana Charoenyingwattana · 1×
Citations per year

Countries citing papers authored by JH Beijnen

Since Specialization
Citations

This map shows the geographic impact of JH Beijnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JH Beijnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JH Beijnen more than expected).

Fields of papers citing papers by JH Beijnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JH Beijnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JH Beijnen. The network helps show where JH Beijnen may publish in the future.

Co-authorship network of co-authors of JH Beijnen

This figure shows the co-authorship network connecting the top 25 collaborators of JH Beijnen. A scholar is included among the top collaborators of JH Beijnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JH Beijnen. JH Beijnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 8
2 12
3 1
4 24
5 9
6 23
7 37
8 103
9 13
10 24
11 27
12 35
13 13
14 3
15 32

About JH Beijnen

JH Beijnen is a scholar working on Toxicology, Hematology and Dermatology, having authored 15 papers that have together received 364 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Virology (63 citations), Toxicology (35 citations) and Infectious Diseases (91 citations). JH Beijnen has collaborated with scholars based in Netherlands, United Kingdom and France. Frequent co-authors include P. L. Meenhorst, Sjoerd Rodenhuis, R. A. A. Maes, JHM Schellens, Elsken van der Wall, Rob ter Heine, Ron A. A. Mathôt, Otilia Dalesio, A. Bult and L.T. Vlasveld. Their work appears in journals such as British Journal of Cancer, Clinical Pharmacology & Therapeutics and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026